Research and experimental development on natural sciences and engineering
PHARMASUM THERAPEUTICS AS
Revenue 2024
NOK 990,000
Operating profit
NOK −2.8m
Equity
NOK −26,000
Incorporated
2014
Share capital
NOK 323,000
Key figures · 2024
Current ratio
3.11
Equity ratio
-1.7%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -286.3% | |
| Net margin (%%) | -284.0% | |
| Return on assets (%%) | -184.7% | |
| Likviditet | ||
| Current ratio | 3.11 | |
| Working capital | 1.0m | |
| Soliditet | ||
| Equity ratio (%%) | -1.7% | |
| Debt-to-equity ratio | -61.00 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.